ATE511845T1 - Verwendung von isothicyanat-derviaten als myelom- bekämpfende wirkstoffe - Google Patents

Verwendung von isothicyanat-derviaten als myelom- bekämpfende wirkstoffe

Info

Publication number
ATE511845T1
ATE511845T1 AT08100658T AT08100658T ATE511845T1 AT E511845 T1 ATE511845 T1 AT E511845T1 AT 08100658 T AT08100658 T AT 08100658T AT 08100658 T AT08100658 T AT 08100658T AT E511845 T1 ATE511845 T1 AT E511845T1
Authority
AT
Austria
Prior art keywords
myeloma
derviates
isothicyanate
actives
fighting
Prior art date
Application number
AT08100658T
Other languages
English (en)
Inventor
Paolo Morazzoni
Carla Manzotti
Gabriele Fontana
Antonella Riva
Renato Iori
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE511845T1 publication Critical patent/ATE511845T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT08100658T 2008-01-18 2008-01-18 Verwendung von isothicyanat-derviaten als myelom- bekämpfende wirkstoffe ATE511845T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08100658A EP2080516B1 (de) 2008-01-18 2008-01-18 Verwendung von Isothicyanat-Derviaten als Myelom-bekämpfende Wirkstoffe

Publications (1)

Publication Number Publication Date
ATE511845T1 true ATE511845T1 (de) 2011-06-15

Family

ID=39247811

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08100658T ATE511845T1 (de) 2008-01-18 2008-01-18 Verwendung von isothicyanat-derviaten als myelom- bekämpfende wirkstoffe

Country Status (17)

Country Link
US (1) US8772251B2 (de)
EP (1) EP2080516B1 (de)
JP (1) JP5386507B2 (de)
KR (1) KR101523042B1 (de)
CN (1) CN101918006B (de)
AT (1) ATE511845T1 (de)
AU (1) AU2008347390B2 (de)
CA (1) CA2712258C (de)
DK (1) DK2080516T3 (de)
ES (1) ES2363385T3 (de)
HR (1) HRP20110451T1 (de)
IL (1) IL207011A (de)
PL (1) PL2080516T3 (de)
PT (1) PT2080516E (de)
RU (1) RU2480217C2 (de)
SI (1) SI2080516T1 (de)
WO (1) WO2009089889A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
US8987316B2 (en) 2011-09-23 2015-03-24 DoubleHill GmbH Isocyanate and isothiocyanate compounds for cancer treatment
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
WO2014018874A1 (en) 2012-07-26 2014-01-30 The William M. Yarbrough Foundation Method for treating skin cancer
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
CN103262850B (zh) * 2013-01-16 2014-06-11 长沙理工大学 一种石蒜生长促进剂及其使用方法
US9949961B2 (en) 2013-03-14 2018-04-24 Rahimdzhan Roziev Agent for the prophylaxis and/or treatment of neoplastic diseases
AU2014342214B2 (en) 2013-11-01 2020-05-21 Rutgers, The State University Of New Jersey Extracts from plants of the Moringaceae family and methods of making
EP3078371A1 (de) * 2015-04-10 2016-10-12 INDENA S.p.A. Verwendung von isothiocyanatderviaten als modulatoren von peripheren und neuropathischen schmerzen
CN107857781A (zh) * 2017-11-16 2018-03-30 云南农业大学 一种从辣木籽中制备4‑α‑L‑鼠李糖基‑异硫氰酸苄酯的方法
EP4534542A1 (de) * 2023-10-02 2025-04-09 Universidad de Sevilla Thiozuckerbasierte isothiocyanate und verwendungen davon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002015722A2 (en) * 2000-08-21 2002-02-28 Fahey Jed W Treatment of helicobacter with isothiocyanates
US6988664B1 (en) * 2004-09-30 2006-01-24 Symbol Technologies, Inc. Removable cover for an electronic device
WO2006065736A2 (en) 2004-12-14 2006-06-22 Johns Hopkins University Method of extraction of isothiocyanates into oil from glucosinolsate-containing plants

Also Published As

Publication number Publication date
SI2080516T1 (sl) 2011-09-30
ES2363385T3 (es) 2011-08-02
RU2010129238A (ru) 2012-01-20
IL207011A0 (en) 2010-12-30
CA2712258A1 (en) 2009-07-23
KR20100102660A (ko) 2010-09-24
KR101523042B1 (ko) 2015-05-26
JP5386507B2 (ja) 2014-01-15
JP2011509955A (ja) 2011-03-31
US8772251B2 (en) 2014-07-08
AU2008347390B2 (en) 2014-03-13
DK2080516T3 (da) 2011-07-11
IL207011A (en) 2014-04-30
HRP20110451T1 (hr) 2011-07-31
PL2080516T3 (pl) 2011-12-30
CN101918006A (zh) 2010-12-15
EP2080516B1 (de) 2011-06-08
EP2080516A1 (de) 2009-07-22
CN101918006B (zh) 2012-11-21
CA2712258C (en) 2013-12-10
PT2080516E (pt) 2011-07-01
AU2008347390A1 (en) 2009-07-23
US20110053870A1 (en) 2011-03-03
RU2480217C2 (ru) 2013-04-27
WO2009089889A1 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
ATE511845T1 (de) Verwendung von isothicyanat-derviaten als myelom- bekämpfende wirkstoffe
IL284991A (en) Antibodies against cd38 for treatment of multiple myeloma
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
CY1120102T1 (el) Συνθεσεις και μεθοδοι για μειωση τριγλυκεριδιων χωρις αυξηση επιπεδων ldl-c σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
EA201100037A1 (ru) Органические соединения
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
EA201270257A1 (ru) Производные n1-сульфонил-5-фторпиримидинона
SMT201500206B (it) Composti spiro-ossindolici e loro uso come agenti terapeutici
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
DK2346321T4 (da) Sammensætning til forbedring af effektiviteten af herbicider
DOP2010000225A (es) Arilpirrolinas insecticidas
CR20120183A (es) PIPERIDINAS SUSTITUIDAS QUE AUMENTAN LA ACTIVIDAD DE p53 Y SUS USOS
EP2249861A4 (de) Behandlung von neurodegenerativen erkrankungen mit progranulin (pgrn)
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
UY31688A1 (es) Plaguicidas
UY31562A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
UY31560A1 (es) Azolilmetiloxiranos, su uso y agentes que los contienen
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
BRPI0808246A2 (pt) "fralda descartável".
EA201000258A1 (ru) Новые гербициды
EA201270253A1 (ru) Производные n1-ацил-5-фторпиримидинона
DE602006013636D1 (de) Dosiszähler
BR112012007888A2 (pt) "métodos de tratamento usando anticorpos anti-ldl oxidada".

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2080516

Country of ref document: EP